Yellow Skin Around the Eyes (Periorbital Jaundice) - Causes, Treatment & When to See a Doctor

What is Yellow Skin Around the Eyes (Periorbital Jaundice)?

Periorbital jaundice, commonly described as “yellow skin around the eyes,” is a visible yellow‑tinged discoloration of the thin skin that surrounds the eyelids and the inner corners of the eyes. The change in color occurs when bilirubin—a yellow pigment produced from the normal breakdown of red blood cells—accumulates in the bloodstream and deposits in tissues with a rich supply of blood vessels and low‑fat content, such as the periorbital area.

While a slight yellow hue may be harmless in newborns (physiologic jaundice), in adults it often signals an underlying disturbance in the liver, gallbladder, pancreas, or blood‑processing system. Recognizing periorbital jaundice early can help identify serious medical conditions before they progress.

Sources: Mayo Clinic – Jaundice; WHO – Jaundice Fact Sheet.

Common Causes

Periorbital jaundice is a symptom, not a disease. The following are the most frequent conditions that raise bilirubin levels enough to produce a yellow eye ring.

• Hepatitis (viral, alcoholic, autoimmune) – Inflammation damages liver cells, impairing bilirubin processing.
• Circum‑portal (or intra‑hepatic) cholestasis – Bile flow is blocked within the liver, causing bilirubin to back up.
• Gallstones or biliary obstruction – A stone or tumor in the bile ducts prevents bilirubin excretion.
• Primary sclerosing cholangitis (PSC) – Chronic scarring of the bile ducts leads to progressive cholestasis.
• Pancreatic cancer (head of pancreas) – Tumors can compress the common bile duct.
• Hemolytic anemia – Accelerated breakdown of red blood cells creates excess bilirubin.
• Gilbert’s syndrome – A benign genetic defect that reduces the liver’s ability to conjugate bilirubin.
• Drug‑induced liver injury – Acetaminophen overdose, certain antibiotics, or chemotherapy agents.
• Septicemia or severe infection – Systemic inflammation can impair liver function.
• Newborn physiologic jaundice – Immature liver enzyme systems in infants; typically resolves within 2 weeks.

Associated Symptoms

Other signs that commonly appear alongside periorbital jaundice give clues about the root cause.

• Generalized yellowing of the skin (especially on the palms and soles)
• Dark urine (tea‑colored) and pale, clay‑colored stools
• Itching (pruritus) without rash
• Abdominal pain or fullness, particularly in the right upper quadrant
• Unexplained weight loss or loss of appetite
• Fatigue, weakness, or dizziness
• Fever, chills, or signs of infection
• Abdominal swelling (ascites) or swelling in the legs
• Bruising or easy bleeding (suggests impaired clotting)
• Confusion, trouble concentrating, or “eyes‑out‑of‑focus” – possible hepatic encephalopathy

When to See a Doctor

The presence of yellow eyes alone does not always require urgent care, but the following situations should trigger a prompt medical evaluation:

• Yellow discoloration persists for more than a few days or worsens.
• Accompanying dark urine, pale stools, or intense itching.
• Severe abdominal pain, especially in the upper right quadrant.
• Fever > 100.4 °F (38 °C) or unexplained chills.
• Sudden weight loss, loss of appetite, or persistent nausea/vomiting.
• Bleeding gums, easy bruising, or prolonged clotting times.
• Confusion, drowsiness, or difficulty staying awake.
• History of liver disease, recent travel to endemic hepatitis regions, or recent use of hepatotoxic medications.

Early consultation helps identify reversible causes (e.g., medication change) and prevents progression to liver failure.

Diagnosis

Diagnosing the underlying cause of periorbital jaundice involves a stepwise approach:

1. Medical History & Physical Exam – Review of symptom timeline, medication list, alcohol use, travel, and family history. The clinician will examine the eyes, abdomen, and signs of chronic liver disease.
2. Blood Tests
   • Total bilirubin* and direct (conjugated) vs. indirect (unconjugated) bilirubin – Determines if the problem is pre‑ or post‑hepatic.
   • Liver enzyme panel* (AST, ALT, ALP, GGT) – Detects inflammation, cholestasis, or cellular injury.
   • Complete blood count (CBC)* – Looks for anemia or infection.
   • Coagulation profile (PT/INR)* – Assesses liver synthetic function.
   • Serologic tests* for viral hepatitis (HAV, HBV, HCV), autoimmune markers (ANA, ASMA), and metabolic disorders.
3. Imaging Studies
   • Ultrasound of the liver and biliary tree – First‑line for stones, duct dilation, or masses.
   • CT or MRCP (magnetic resonance cholangiopancreatography) – Provides detailed views of the pancreas and bile ducts.
   • FibroScan or elastography – Estimates liver fibrosis non‑invasively.
4. Specialized Tests
   • Endoscopic retrograde cholangiopancreatography (ERCP) – Both diagnostic and therapeutic for ductal obstruction.
   • Liver biopsy – Reserved for unclear cases or suspected autoimmune/hemochromatosis disease.

’*Values may vary by laboratory; always interpret in clinical context.

Treatment Options

Treatment targets the root cause, not the discoloration itself. Below are the main therapeutic pathways.

Medical Management

• Antiviral therapy for chronic hepatitis B or C (e.g., tenofovir, entecavir, direct‑acting antivirals).
• Corticosteroids or immunosuppressants for autoimmune hepatitis.
• Ursodeoxycholic acid (UDCA) for cholestatic diseases such as primary biliary cholangitis.
• Antibiotics** for bacterial cholangitis (e.g., ceftriaxone followed by oral fluoroquinolone).
• Chemo‑ or radiotherapy when a malignancy (pancreatic or cholangiocarcinoma) is identified.
• Blood transfusion or erythropoietin for severe hemolytic anemia.
• Medication review – Discontinuing hepatotoxic drugs or adjusting dosages.
• Supportive care – Intravenous fluids, nutritional support, and vitamin K if coagulopathy is present.

Procedural Interventions

• Endoscopic stone extraction or stent placement for choledocholithiasis.
• Percutaneous transhepatic biliary drainage in obstructive jaundice when ERCP is not feasible.
• Liver transplantation for end‑stage liver disease not amenable to other therapies.

Home & Lifestyle Measures

• Hydration – Adequate fluid intake helps maintain bile flow.
• Low‑fat diet – Reduces burden on the liver and gallbladder.
• Avoid alcohol – Even moderate consumption can worsen bilirubin elevation.
• Sun protection – Jaundiced skin is more sensitive to UV light; use sunscreen.
• Itch relief – Cool compresses, oatmeal baths, or over‑the‑counter antihistamines; prescription cholestyramine can bind bile acids causing pruritus.
• Regular monitoring – Keep scheduled follow‑up labs to track bilirubin trends.

Prevention Tips

Because many causes are linked to lifestyle or preventable conditions, the following strategies lower the risk of developing periorbital jaundice.

• Maintain a healthy weight; obesity increases fatty liver disease risk.
• Limit alcohol to ≤ 1 drink per day for women and ≤ 2 for men, or abstain if liver disease is present.
• Vaccinate against hepatitis A and B; practice safe sex and avoid sharing needles.
• Use medications as prescribed; avoid unnecessary over‑the‑counter remedies that can be hepatotoxic (e.g., high‑dose acetaminophen).
• Follow a balanced diet rich in fruits, vegetables, whole grains, and lean protein; consider the Mediterranean diet for liver health.
• Practice good hygiene to reduce infections that could progress to sepsis.
• Regularly screen for diabetes and lipid disorders, which can contribute to non‑alcoholic fatty liver disease (NAFLD).
• Schedule routine health checks, especially if you have a family history of liver or gallbladder disease.

Emergency Warning Signs

If you experience any of the following, seek emergency medical care (call 911 or go to the nearest emergency department) immediately:

• Sudden, severe abdominal pain especially in the upper right quadrant.
• Rapidly worsening jaundice accompanied by confusion, drowsiness, or unusual behavior (possible hepatic encephalopathy).
• High fever (> 102 °F/38.9 °C) with chills and jaundice – may indicate cholangitis.
• Vomiting blood (hematemesis) or black, tarry stools (melena) – signs of gastrointestinal bleeding.
• Signs of severe bleeding: nosebleeds, gum bleeding, or bleeding that won’t stop.
• Sudden loss of consciousness or severe dizziness.

Timely intervention can be life‑saving, especially when the underlying cause is an infection, biliary obstruction, or acute liver failure.

References: 1. Mayo Clinic. “Jaundice.” https://www.mayoclinic.org/symptoms/jaundice/basics/definition/sym-20050889. 2. CDC. “Hepatitis A, B, C.” https://www.cdc.gov/hepatitis/. 3. NIH – National Institute of Diabetes and Digestive and Kidney Diseases. “Liver Disease.” https://www.niddk.nih.gov/health-information/liver-disease. 4. Cleveland Clinic. “Gallstones and Biliary Colic.” https://my.clevelandclinic.org/health/diseases/4283-gallstones. 5. WHO. “Jaundice Fact Sheet.” https://www.who.int/news-room/fact-sheets/detail/jaundice. 6. UpToDate. “Evaluation of the adult with jaundice.” (accessed May 2026).